Encore Medical, Inc（EMI）美股招股说明书 S-1（2026-07-01修订版）（英文版）（134页）.pdf

1、Large accelerated filerAccelerated filerNon-accelerator filerSmaller reporting companyEmerging growth companyS-1/A 1 tm2525595-12_s1a.htm S-1/ATABLE OF CONTENTSREGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JUNE 30,2026Registration No.3

2、33-290244 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549AMENDMENT NO.5TOFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933ENCORE MEDICAL,INC.(Exact name of registrant as specified in its charter)Minnesota(State or other jurisdiction ofincorporation or organization)384

3、1(Primary Standard IndustrialClassification Code Number)82-2906303(I.R.S.EmployerIdentification Number)2975 Lone Oak Drive,Suite 140Eagan,MN 55121Telephone:(651)797-0913(Address,including zip code,and telephone number,including area code,of registrants principal executive offices)Joseph A.MarinoPres

4、ident and Chief Executive OfficerEncore Medical,Inc.2975 Lone Oak Drive,Suite 140Eagan,MN 55121Telephone:(651)797-0913(Name,address,including zip code,and telephone number,including area code,of agent for service)Copies to:Amy BowlerHolland&Hart LLP555 17 Street,Suite 3200Denver,CO 80202Telephone:(3

5、03)295-8000 William M.MowerAndrew M.TatarynMaslon LLP225 South 6 Street,Suite 2900Minneapolis,MN 55402Telephone:(612)672-8381 APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:AS SOON AS PRACTICABLE AFTER THE EFFECTIVE DATE OF THIS REGISTRATION STATEMENT.If any of the securities being

6、registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 underthe Securities Act of 1933,check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,check thefollowing box and l